nodes	percent_of_prediction	percent_of_DWPC	metapath
Medrysone—Corticosteroid Hormone Receptor Agonists—Prednisone—systemic scleroderma	0.509	1	CiPCiCtD
Medrysone—NR3C1—Mometasone—systemic scleroderma	0.152	0.759	CbGbCtD
Medrysone—NR3C1—Prednisone—systemic scleroderma	0.0482	0.241	CbGbCtD
Medrysone—Fluocortolone—Mometasone—systemic scleroderma	0.022	0.0824	CrCrCtD
Medrysone—Paramethasone—Mometasone—systemic scleroderma	0.0198	0.074	CrCrCtD
Medrysone—Loteprednol—Mometasone—systemic scleroderma	0.0188	0.0705	CrCrCtD
Medrysone—Fluorometholone—Mometasone—systemic scleroderma	0.0188	0.0705	CrCrCtD
Medrysone—Rimexolone—Mometasone—systemic scleroderma	0.0184	0.0689	CrCrCtD
Medrysone—Methylprednisolone—Mometasone—systemic scleroderma	0.0176	0.0659	CrCrCtD
Medrysone—Prednisolone—Mometasone—systemic scleroderma	0.0172	0.0645	CrCrCtD
Medrysone—Hydrocortisone—Mometasone—systemic scleroderma	0.0165	0.0619	CrCrCtD
Medrysone—Hydrocortamate—Prednisone—systemic scleroderma	0.0131	0.0492	CrCrCtD
Medrysone—Cortisone acetate—Prednisone—systemic scleroderma	0.0127	0.0476	CrCrCtD
Medrysone—Fluocortolone—Prednisone—systemic scleroderma	0.012	0.0449	CrCrCtD
Medrysone—Paramethasone—Prednisone—systemic scleroderma	0.0108	0.0403	CrCrCtD
Medrysone—Methyltestosterone—Prednisone—systemic scleroderma	0.0108	0.0403	CrCrCtD
Medrysone—Loteprednol—Prednisone—systemic scleroderma	0.0103	0.0384	CrCrCtD
Medrysone—Fluorometholone—Prednisone—systemic scleroderma	0.0103	0.0384	CrCrCtD
Medrysone—Rimexolone—Prednisone—systemic scleroderma	0.01	0.0376	CrCrCtD
Medrysone—Methylprednisolone—Prednisone—systemic scleroderma	0.0096	0.0359	CrCrCtD
Medrysone—Prednisolone—Prednisone—systemic scleroderma	0.0094	0.0352	CrCrCtD
Medrysone—Hydrocortisone—Prednisone—systemic scleroderma	0.00902	0.0337	CrCrCtD
Medrysone—Hyperadrenocorticism—Mometasone—systemic scleroderma	0.00444	0.185	CcSEcCtD
Medrysone—Impaired healing—Mometasone—systemic scleroderma	0.00159	0.0662	CcSEcCtD
Medrysone—Ulcerative keratitis—Mycophenolate mofetil—systemic scleroderma	0.00148	0.0618	CcSEcCtD
Medrysone—Nerve injury—Prednisone—systemic scleroderma	0.00116	0.0484	CcSEcCtD
Medrysone—Impaired healing—Mycophenolic acid—systemic scleroderma	0.0011	0.0457	CcSEcCtD
Medrysone—Ulcerative keratitis—Prednisone—systemic scleroderma	0.001	0.0419	CcSEcCtD
Medrysone—Cataract subcapsular—Prednisone—systemic scleroderma	0.000972	0.0405	CcSEcCtD
Medrysone—Glaucoma—Mometasone—systemic scleroderma	0.000912	0.038	CcSEcCtD
Medrysone—Impaired healing—Mycophenolate mofetil—systemic scleroderma	0.000866	0.0361	CcSEcCtD
Medrysone—Stinging—Mometasone—systemic scleroderma	0.000848	0.0353	CcSEcCtD
Medrysone—Viral infection—Mometasone—systemic scleroderma	0.00076	0.0317	CcSEcCtD
Medrysone—Impaired healing—Prednisone—systemic scleroderma	0.000587	0.0245	CcSEcCtD
Medrysone—Keratitis—Mycophenolate mofetil—systemic scleroderma	0.000577	0.0241	CcSEcCtD
Medrysone—Viral infection—Mycophenolic acid—systemic scleroderma	0.000525	0.0219	CcSEcCtD
Medrysone—Impaired healing—Methotrexate—systemic scleroderma	0.00049	0.0204	CcSEcCtD
Medrysone—Viral infection—Lisinopril—systemic scleroderma	0.000473	0.0197	CcSEcCtD
Medrysone—Conjunctivitis—Pentoxifylline—systemic scleroderma	0.000433	0.018	CcSEcCtD
Medrysone—Conjunctivitis—Mometasone—systemic scleroderma	0.000373	0.0156	CcSEcCtD
Medrysone—Glaucoma—Prednisone—systemic scleroderma	0.000337	0.014	CcSEcCtD
Medrysone—Vision blurred—Pentoxifylline—systemic scleroderma	0.000328	0.0137	CcSEcCtD
Medrysone—Visual disturbance—Mycophenolate mofetil—systemic scleroderma	0.000287	0.012	CcSEcCtD
Medrysone—Viral infection—Prednisone—systemic scleroderma	0.000281	0.0117	CcSEcCtD
Medrysone—Conjunctivitis—Leflunomide—systemic scleroderma	0.00027	0.0113	CcSEcCtD
Medrysone—Conjunctivitis—Mycophenolic acid—systemic scleroderma	0.000258	0.0108	CcSEcCtD
Medrysone—Vision blurred—Captopril—systemic scleroderma	0.000249	0.0104	CcSEcCtD
Medrysone—Visual impairment—Mycophenolic acid—systemic scleroderma	0.00023	0.00957	CcSEcCtD
Medrysone—Pain—Mometasone—systemic scleroderma	0.00021	0.00874	CcSEcCtD
Medrysone—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000209	0.00872	CcSEcCtD
Medrysone—Vision blurred—Leflunomide—systemic scleroderma	0.000205	0.00854	CcSEcCtD
Medrysone—Conjunctivitis—Mycophenolate mofetil—systemic scleroderma	0.000204	0.00848	CcSEcCtD
Medrysone—Vision blurred—Mycophenolic acid—systemic scleroderma	0.000195	0.00815	CcSEcCtD
Medrysone—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.000181	0.00755	CcSEcCtD
Medrysone—Vision blurred—Lisinopril—systemic scleroderma	0.000176	0.00734	CcSEcCtD
Medrysone—Visual disturbance—Methotrexate—systemic scleroderma	0.000162	0.00677	CcSEcCtD
Medrysone—Pain—Leflunomide—systemic scleroderma	0.000152	0.00632	CcSEcCtD
Medrysone—Pain—Mycophenolic acid—systemic scleroderma	0.000145	0.00603	CcSEcCtD
Medrysone—Hypersensitivity—Azathioprine—systemic scleroderma	0.000138	0.00577	CcSEcCtD
Medrysone—Hypersensitivity—Leflunomide—systemic scleroderma	0.000131	0.00545	CcSEcCtD
Medrysone—Pain—Lisinopril—systemic scleroderma	0.00013	0.00543	CcSEcCtD
Medrysone—Conjunctivitis—Methotrexate—systemic scleroderma	0.000115	0.00481	CcSEcCtD
Medrysone—Pain—Mycophenolate mofetil—systemic scleroderma	0.000114	0.00476	CcSEcCtD
Medrysone—Hypersensitivity—Lisinopril—systemic scleroderma	0.000112	0.00468	CcSEcCtD
Medrysone—Vision blurred—Prednisone—systemic scleroderma	0.000105	0.00436	CcSEcCtD
Medrysone—Visual impairment—Methotrexate—systemic scleroderma	0.000103	0.00428	CcSEcCtD
Medrysone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	9.84e-05	0.0041	CcSEcCtD
Medrysone—Vision blurred—Methotrexate—systemic scleroderma	8.74e-05	0.00364	CcSEcCtD
Medrysone—Hypersensitivity—Prednisone—systemic scleroderma	6.67e-05	0.00278	CcSEcCtD
Medrysone—Pain—Methotrexate—systemic scleroderma	6.47e-05	0.0027	CcSEcCtD
Medrysone—Hypersensitivity—Methotrexate—systemic scleroderma	5.57e-05	0.00232	CcSEcCtD
